Christine Tunon de Lara is an expert in Oncology at Institut Bergonié (France). Christine Tunon de Lara has authored 100 publications, the most recent in 2023, and is an investigator in 7 clinical trials. SLR score: 242 (community average: 125). How the SLR is computed.

LeadR Profile

Christine Tunon de Lara Institut Bergonié France
242 ScienceLeadR Reputation 242
Network Map

Oncology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2023

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 100

Citations

Citations: 3 205 1st author: 10 Last author: 9 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Re: Axillary lymph node dissection.
PMID 37263895 — dissection, lymph nodes, general surgery
J Visc Surg20230
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.
PMID 36127853 — lymph nodes, breast neoplasms, neoplasms, neoplasm metastasis, lymph, breast, therapeutics, dissection, prognosis
Cancer Med202211
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study.
PMID 36194904 — breast neoplasms, retrospective studies, neoplasms, breast, therapeutics
Eur J Cancer20222
Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
PMID 35523623 — radiotherapy, mastectomy, safety, breast neoplasms, neoplasms, drug therapy, mammaplasty, breast, therapeutics, medical oncology, chemotherapy
Eur J Surg Oncol202211
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.
PMID 35263698 — breast neoplasms, genes, brca1, mutation
Cancer Genet20222

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

N/A 6
Phase 3 1

By status:

Completed 3
Recruiting 2
Active not recruiting 1
Terminated 1

By type:

Interventional 5
Observational 2

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map